Centene Securities Class Action Lawsuit
Analysis based on 7 articles · First reported Jul 11, 2025 · Last updated Aug 12, 2025
The market is impacted by the significant decline in Centene Corporation's stock price due to the withdrawal of its 2025 guidance and the subsequent federal securities class action lawsuit. This event highlights potential risks for investors in the healthcare sector regarding company disclosures and financial projections.
Centene Corporation is facing a federal securities class action lawsuit filed by Faruqi & Faruqi. The lawsuit alleges that Centene Corporation provided false and misleading statements to investors concerning its enrollment and morbidity rates between December 12, 2024, and June 30, 2025. On July 1, 2025, Centene Corporation withdrew its 2025 guidance, citing lower-than-expected market growth in its Health Insurance Marketplace across 22 states. This preliminary analysis resulted in a reduction of its guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. Following this announcement, Centene Corporation's common stock dramatically declined by 40.4%, from $56.65 to $33.78 per share, on July 2, 2025. Faruqi & Faruqi is encouraging investors who suffered losses to contact them to discuss their legal rights and the September 8, 2025, deadline to seek the role of lead plaintiff.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard